"GE HealthCare's full-year 2025 revenue grew 4.84% to $20.625 billion, the slowest growth rate in the group, with adjusted EPS of $4.59 beating estimates by 0.85%."
"Tariffs were a significant headwind for GE HealthCare, absorbing an estimated $245 million in adjusted EBIT impacts and approximately $0.43 per share to adjusted EPS."
"GE Vernova's Q4 2025 backlog reached a record $150 billion, with organic order growth of 65%, driven by strong demand in the Power segment."
General Electric's breakup led to three separate public companies focusing on aerospace, energy transition, and medical technology. GE HealthCare, the smallest, reported a 4.84% revenue growth for 2025, with adjusted EPS of $4.59. Tariffs impacted earnings significantly, causing a decline in GAAP net income and free cash flow. GE Vernova, focused on energy transition, achieved a record backlog of $150 billion in Q4 2025, with 65% organic order growth. Each company has distinct financial metrics and growth trajectories, influencing investor sentiment and market performance.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]